Raynaud’s disease is a vascular disorder in which a spasm of small arteries occurs, leading to a violation of blood supply to the hands, legs, ears and nose.
🔹 Features of Raynaud’s disease
Reason: an excessive vascular reaction to cold or stress.
At risk: women and men 20–40 years old, people with autoimmune diseases.
📌 Types:
Raynaud’s primary disease – without communication with other diseases.
Secondary (Raynaud syndrome) – develops with autoimmune pathologies (SLE, Scleroderma, Vasculitis).
🔹 The first manifestations of Raynaud’s disease
1. Changing the color of the fingers (2 phases)
🔵 1 phase-ischemia (blood vessels are narrowed)-fingers turn pale due to lack of blood.
🔴 2 phase – hypoxia (oxygen starvation) – the skin becomes blue.
2. Sensations during an attack
✔️ numbness, tingling.
✔️ Pain, burning with thawing.
✅ Blood tests:
ANA antibodies, anti-central antibodies (with suspected autoimmune diseases).
Rheumatoid factor, C-reactive protein.
Reino’s disease and Raynaud’ssyndrome are two conditions with similar symptoms, but differing in reasons and approaches to treatment.
____________________________________________
Raynaud’s disease (primary phenomenon of Raynaud):
• reason: unknown (idiopathic); It is considered an independent disease.
• Characteristic: more often found in women 20–40 years; It proceeds softer, less often leads to complications.
• treatment: aimed at preventing symptoms and improving the quality of life; Includes the avoidance of provoking factors, the use of vasodilating drugs.
____________________________________________
Raynaud’s Syndrome (secondary phenomenon of Raynaud’s):
• The reason: occurs against the background of other diseases, such as systemic scleroderma, lupus, rheumatoid arthritis.
• Characterization: can manifest at any age; Symptoms are more pronounced; Above the risk of complications, including ulcers and necrosis of tissues.
• Treatment: includes the therapy of the underlying disease causing Reino syndrome, and measures to improve peripheral circulation.
Treatment of Raynaud’s disease with stem cells is considered as an innovative approach aimed at restoring blood circulation in affected limbs and preventing the progression of the disease. Stem cells have the ability to differentiate into various types of tissues and stimulate vascular regeneration, which can improve tissue trophic and reduce inflammation.
Potential advantages of stem cell therapy for Raynaud’s disease:
• Restoration of blood circulation: stimulation of the formation of new vessels helps to improve blood supply in affected areas.• Reducing inflammation: immunomodulating properties of stem cells can reduce inflammatory processes in tissues.
• Improving tissue trophic: improving oxygen delivery and nutrients contributes to healing and restoration of tissues.
The progenitor stem cells, in particular endothelial progenitor cells (EPC), are a promising direction in regenerative medicine for the treatment of Reino’s disease. These cells have the ability to differentiate into endothelial cells, which helps to restore damaged vessels and improve microcirculation in peripheral tissues.
How does this work?
• Vascular restoration: EPC can stimulate not only angiogenesis (the formation of new blood vessels), but also remodeling of existing vessels, improving blood flow in the affected limbs.
• Reducing vascular cramps: improved blood supply helps reduce vasospasm attacks characteristic of Reino’s disease.
• anti -inflammatory effect: the use of progenitor cells can help reduce local inflammation, which also has a beneficial effect on the function of blood.
Clinical data and prospects
Clinical studies show that such therapy can reduce the severity of symptoms at any stage of the progression of the disease. But before using this therapy, it is important:
• Carry out comprehensive diagnostics to assess the degree of vascular disorders.
• Discuss potential benefits with a specialist in regenerative medicine.
Endothelial progenitor cells are one of the most promising technologies for the treatment of diseases associated with impaired peripheral circulation, such as Reino’s disease.
The clinical results of the use of stem cells in the disease of Reino show encouraging trends.
The main observed effects include:
• Improving peripheral blood circulation: stem cells contribute to angiogenesis, that is, the formation of new blood vessels, which improves blood flow to the affected limbs.
• Reducing the frequency and severity of attacks: many patients note a decrease in the number of vascular cramps and softening symptoms (pain, numbness, skin color change) after the administration of cell therapy.
• The regeneration of the damaged vascular wall: the use of donor meshimal stem cells helps to restore the structure of blood vessels, which can slow down the progression of the disease.
Patient Review after the treatment of Raynaud’s disease (after 6 days)
